Skip to main content
Top
Published in: World Journal of Urology 4/2009

01-08-2009 | Original Article

Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

Authors: Magnus Holmer, Pär-Ola Bendahl, Thomas Davidsson, Sigurdur Gudjonsson, Wiking Månsson, Fredrik Liedberg

Published in: World Journal of Urology | Issue 4/2009

Login to get access

Abstract

Objective

We compared extended and limited lymph node dissections performed during radical cystectomy with regard to impact on survival and time to recurrence in bladder cancer patients.

Methods

We analyzed 170 patients who underwent radical cystectomy for urothelial carcinoma between January 1997 and December 2005. From 1997 to 2000, 69 of the patients were subjected to limited lymph dissection that included perivesical nodes and nodes in the obturator fossa. In 2001–2005, the remaining 101 patients underwent extended lymph dissection that included perivesical nodes; nodes in the obturator fossa; the internal, external, and common iliac nodes; and the presacral nodes.

Results

Tumors penetrating the bladder wall (pT3 and pT4a) were more common in the extended than in the limited dissection group (48 and 33%, respectively). The median numbers of lymph nodes removed in the two groups were 37 and 8, respectively. Lymph node metastases were detected in 38% of the extended dissection patients but only in 17% of the limited dissection patients. There was no significant difference in survival or time to recurrence between the two groups. Subgroup analyses showed a significantly longer time to recurrence (HR 0.45, 95% CI 0.22–0.93; P = 0.032) in patients with non-organ-confined disease who underwent extended lymph node dissection. In a multivariate analysis adjusting for tumor stage, lymph node status, age, sex, and adjuvant chemotherapy, there was a significantly improved survival (HR 0.47, 95% CI 0.25–0.88; P = 0.018) and time to recurrence (HR 0.42, 95% CI 0.23–0.79; P = 0.007) in the patients with extended lymph node dissections.

Conclusions

Extended lymph node dissection did not improve disease-specific survival, but was in multivariate analysis related to significantly improved disease-specific survival and prolonged time to recurrence in radical cystectomy patients. These results should be interpreted cautiously, since they might have been affected by stage migration and the shorter follow-up in the extended dissection group.
Literature
1.
go back to reference Nationellt kvalitetsregister för blåscancer (2004) Diagnosår 2004. Socialstyrelsen, Svensk Urologisk Förening, Sveriges Onkologiska Centra 1:5–11 Nationellt kvalitetsregister för blåscancer (2004) Diagnosår 2004. Socialstyrelsen, Svensk Urologisk Förening, Sveriges Onkologiska Centra 1:5–11
2.
go back to reference Thalmann G, Fleischmann A, Mills DR, Burkhard CF, Markwalder R, Studer EU (2003) Lymphadenectomy in bladder cancer. EAU Update Series 1:100–107CrossRef Thalmann G, Fleischmann A, Mills DR, Burkhard CF, Markwalder R, Studer EU (2003) Lymphadenectomy in bladder cancer. EAU Update Series 1:100–107CrossRef
3.
go back to reference Kerr WS, Colby F (1950) Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J Urol 63:842–851 Kerr WS, Colby F (1950) Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J Urol 63:842–851
4.
go back to reference Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34–36PubMed Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34–36PubMed
5.
go back to reference Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015–2020PubMedCrossRef Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015–2020PubMedCrossRef
6.
go back to reference Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int 85:817–823PubMedCrossRef Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int 85:817–823PubMedCrossRef
7.
go back to reference Herr HW, Bochner BH, Dalbagnis G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298PubMedCrossRef Herr HW, Bochner BH, Dalbagnis G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298PubMedCrossRef
8.
go back to reference Konety BR, Joslyn SA, O’Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from Surveillance, Epidemiology and End Results Program data base. J Urol 169:946–950PubMedCrossRef Konety BR, Joslyn SA, O’Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from Surveillance, Epidemiology and End Results Program data base. J Urol 169:946–950PubMedCrossRef
9.
go back to reference Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W (2006) Intraoperative sentinel node detection improves staging in invasive bladder cancer. J Urol 175:84–89PubMedCrossRef Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W (2006) Intraoperative sentinel node detection improves staging in invasive bladder cancer. J Urol 175:84–89PubMedCrossRef
10.
go back to reference Sobin LH, Wittekind CL (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York Sobin LH, Wittekind CL (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
11.
go back to reference Altman DG (1991) Practical statistics in medical research. Chapman & Hall, London, p 394 Altman DG (1991) Practical statistics in medical research. Chapman & Hall, London, p 394
12.
go back to reference Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef
13.
go back to reference Vazina A, Dudi D, Shariat SF, Evans J, Link R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171(5):1830–1834PubMedCrossRef Vazina A, Dudi D, Shariat SF, Evans J, Link R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171(5):1830–1834PubMedCrossRef
14.
go back to reference Steven K, Poulsen AL (2007) Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 178:1218–1223PubMedCrossRef Steven K, Poulsen AL (2007) Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 178:1218–1223PubMedCrossRef
15.
go back to reference Suttmann H, Kamradt J, Lehmann J, Stöckle M (2007) Improving the prognosis of patients after radical cystectomy. Part I. The role of lymph node dissection. BJU Int 100:1221–1224PubMedCrossRef Suttmann H, Kamradt J, Lehmann J, Stöckle M (2007) Improving the prognosis of patients after radical cystectomy. Part I. The role of lymph node dissection. BJU Int 100:1221–1224PubMedCrossRef
16.
go back to reference Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef
17.
go back to reference Herr HW (2003) Extent of surgery and pathology has an impact on bladder cancer outcomes after radical cystectomy. Urology 61:105–108PubMedCrossRef Herr HW (2003) Extent of surgery and pathology has an impact on bladder cancer outcomes after radical cystectomy. Urology 61:105–108PubMedCrossRef
18.
go back to reference Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G (2004) Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172:1286–1290PubMedCrossRef Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G (2004) Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172:1286–1290PubMedCrossRef
19.
go back to reference Schwartz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastroint Surg 11:1384–1398CrossRef Schwartz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastroint Surg 11:1384–1398CrossRef
20.
go back to reference Siewert JR, Böttcher K, Stein HJ, Roder JD, and the German Gastric Carcinoma Study Group (1998) Relevant prognostic factors in gastric cancer. Ann Surg 161:449–454CrossRef Siewert JR, Böttcher K, Stein HJ, Roder JD, and the German Gastric Carcinoma Study Group (1998) Relevant prognostic factors in gastric cancer. Ann Surg 161:449–454CrossRef
21.
go back to reference Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC (1998) For patients with Dukes’ (TNM Stage II) colorectal carcinoma, examination of six or fever lymph nodes is related to poor prognosis. Cancer 83:666–672PubMedCrossRef Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC (1998) For patients with Dukes’ (TNM Stage II) colorectal carcinoma, examination of six or fever lymph nodes is related to poor prognosis. Cancer 83:666–672PubMedCrossRef
Metadata
Title
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
Authors
Magnus Holmer
Pär-Ola Bendahl
Thomas Davidsson
Sigurdur Gudjonsson
Wiking Månsson
Fredrik Liedberg
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 4/2009
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-008-0366-9

Other articles of this Issue 4/2009

World Journal of Urology 4/2009 Go to the issue